ALITRETINOIN Leman caps moll 30 mg 30 pce

7680688360028 CH-68836 D11AH 10.04.0.

Reimbursement limitations:

ALITRETINOIN

ALITRETINOIN LEMAN est indiqué chez l'adulte souffrant d'un eczéma sévère des mains réfractaire à la …

ALITRETINOIN Leman caps moll 30 mg 30 pce
ALITRETINOIN Leman caps moll 30 mg 30 pce
ALITRETINOIN Leman caps moll 30 mg 30 pce
1 / 3
google

Details

Product number
6883602
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
alitretinoinum 30 mg, sojae oleum raffinatum 261.444 mg, sojae oleum partim hydrogenatum 17.388 mg, oleum vegetabile hydrogenatum, glyceroli monostearas 40-55, triglycerida media, int-rac-alpha-tocopherolum, matériel de la capsule: gelatina, glycerolum, sorbitolum liquidum non cristallisabile corresp. sorbitolum 17.884 mg, E 171, E 172 (flavum), aqua purificata, pro capsula.

Articles (1)

Alitretinoin Leman 30 mg, capsules molles
Weichkapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
20/07/2023
Professional SmPC
Français
20/07/2023
Patient information leaflet
Allemand
10/07/2023
Patient information leaflet
Français
10/07/2023
Patient information leaflet
Italien
10/07/2023

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
261.444 MG Substance HBESI
(N/A)
17.388 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
17.884 MG Substance HBESI
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 199.65
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2023

Authorization holder

Leman SKL SA

1213 Lancy

Authorization information

Swissmedic authorization number
68836
Drug name
Alitretinoin Leman, capsules molles
Galenic form
KAPWE
ATC Code
D11AH
Authorization status
Z
Dispensation category
A
First authorization
29/03/2023
Authorization expiration date
28/03/2028
IT number
10.04.0.
Domain
Human medicine

Packaging details

Description (FR)
ALITRETINOIN Leman caps moll 30 mg 30 pce
Description (DE)
ALITRETINOIN Leman Weichkaps 30 mg 30 Stk
Market launch
29/03/2023
Narcotic (BTM)
No

Other packaging sizes

ALITRETINOIN Leman caps moll 10 mg 30 pce
30 KAP
View